Cue Biopharma, Inc. (CUE)
NASDAQ · Manufacturing · Pharmaceutical preparations
$31.41−$1.44 (−4.38%) on the dayAs of the close; data may be delayed.
CUE price, last 12 months
Key stats
- Previous close
- $32.85
- Open
- $33.12
- Day range
- $30.75 – $33.40
- 52-week range
- $4.97 – $45.50
- Volume
- 232.4K
- Avg volume (20 days)
- 422.4K
- Market cap
- $228.2M
Performance
1W−15.2%
1M+8.9%
3M+23.7%
6M+317.3%
YTD+242.8%
1Y+47.9%
vs S&P 500, 1Y+31.1 pts
Technicals and fundamentals
About Cue Biopharma, Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $228.2M